FIELD: medicine, oncology, pharmacy.
SUBSTANCE: invention proposes a pharmaceutical composition that contains compounds of chlorogenic acid isolated from Piper betel leaves extract or from any other part of plant Piper betel and a pharmaceutically acceptable excipient. Invention provides enhanced effectiveness of treatment of such diseases as acute and chronic myeloid leucosis and lymphoid leucosis and absence of its effect on normal cells. Invention can be used in treatment of patients suffering from acute and chronic myeloid and lymphoid leucosis.
EFFECT: enhanced and valuable medicinal properties of pharmaceutical composition.
32 cl, 4 tbl, 4 dwg, 11 ex
| Title | Year | Author | Number |
|---|---|---|---|
| ANTI-IL1RAP ANTIBODIES AND THEIR USE FOR TREATING HUMAN | 2012 |
|
RU2597831C2 |
| NATURAL ANTITUMOR OR ANTIVIRAL SUBSTANCES AND THEIR APPLICATION | 1998 |
|
RU2205010C2 |
| USE OF COMPOSITION OF COPPER OXIDE NANOPARTICLES AND N-ACETYLCYSTEINE FOR DEATH INDUCTION OF CELLS OF CHRONIC MYELOID LEUKAEMIA | 2019 |
|
RU2721771C1 |
| CANCER TREATMENT | 2005 |
|
RU2389507C2 |
| SALT OF NITROGEN-CONTAINING HETEROCYCLIC COMPOUND OR ITS CRYSTALLINE FORM, PHARMACEUTICAL COMPOSITION AND FLT3 INHIBITOR | 2014 |
|
RU2641106C2 |
| NK INVOLVING MOLECULES AND METHODS OF THEIR USE | 2019 |
|
RU2812481C2 |
| MONOCLONAL ANTIBODY PREPARED USING INTEGRIN-ASSOCIATED PROTEIN, ITS FRAGMENT FAB, FAB' OR F(AB'), HYBRIDOMA PRODUCING MONOCLONAL ANTIBODY (VARIANT), ANTILEUKEMIC AGENT | 1998 |
|
RU2212413C2 |
| CANCER TREATMENT WITH CHIMERIC CD33 ANTIGEN RECEPTOR | 2015 |
|
RU2747384C2 |
| METHODS OF TREATING, DIAGNOSING AND PREDICTING A HEMATOLOGIC MALIGNANT NEOPLASM | 2015 |
|
RU2727418C2 |
| PHARMACEUTICAL COMPOUND | 2018 |
|
RU2786994C2 |
